Evaluation of the Protective Properties of Amlodipine, on Cisplatin Induced Cardiotoxicity in Male Rats

Dr. Ammar Abdulkareem Hadi

Authors

Dr. Ammar Abdulkareem Hadi

Keywords:

cisplatin, amlodipine, cardiotoxicity, troponin, CK-MB

Abstract

This study was aimed to evaluate the cardiotoxicity of cisplatin in rats and to investigate the cardioprotective effect of amlodipine on cisplatin treated rats by using cardiac biomarkers troponin, CK-MB. Thirty five healthy male swiss albino rats were used in this study. The study design was divided into two patterns: Pilot study design: The animals were randomly divided into two groups, In the first treated group, all rats received cisplatin in a single dose, while in the second treated group, rats received cisplatin in four divided doses every 2 days. Active study design: The animals were randomly divided into 3 groups (7 rats/ group) and treated as follows:- a- Normal saline (N.S) treated group. b- Cisplatin treated group. c- Amlodipine treated group with cisplatin. Blood samples were collected and used to determine the biomarkers serum troponin, CK-MB. The result from pilot study shows that in cisplatin treated groups (single dose) serum troponin, CKMB are not significantly change with control group. While, when we give cisplatin in multiple doses, there is a significantly increase in serum troponin, CK-MB. Amlodipine show a potent cardioprorective effect against cisplatin cardiotoxicity.

Downloads

How to Cite

Evaluation of the Protective Properties of Amlodipine, on Cisplatin Induced Cardiotoxicity in Male Rats. (2013). Global Journal of Medical Research, 13(K2), 23-28. https://medicalresearchjournal.org/index.php/GJMR/article/view/338

Download Citation

References

M Rădulescu, C Duncea, D Rădulescu, V Militaru, A Pârv (2011) Cardiotoxicity of antineoplasic agents; onset, risk factors and clinical manifestation. 3(2), 150-157.

C Coppin, M Gospodarowicz, K James, I Tannock, B Zee, J Carson, J Pater, L Sullivan (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.. 14(11), 2901-2907.

Peter Rose, Brian Bundy, Edwin Watkins, J Thigpen, Gunther Deppe, Mitchell Maiman, Daniel Clarke-Pearson, Sam Insalaco (1999) Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer. 340(15), 1144-1153.

U Gatzemeier, J Von Pawel, M Gottfried, G Ten Velde, K Mattson, F Demarinis, P Harper, F Salvati, G Robinet, A Lucenti, J Bogarerts, G Gallant (2000) Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-smallcell lung cancer. 18(19), 3390-3399.

P Hoskins, E Eisenhauer, I Vergote, J Dubuc-Lissoir, B Fisher, R Grimshaw, A Oza, M Plante, G Stuart, J Vermorken (2000) Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paciltaxel/cisplatin as primary treatment of advanced epithelial ovarian cancer. 18(24), 4038-4044.

A Planting, G Catimel, P De Mulder, A De Graeff, F Hoppener, J Verweij, W Oster, D Van-Hoff, R Schilsky, C Reichert (1979) Toxic effects of cis-dichlorodiammine platinum in man. 63, 1527-1531.

Ana-Maria Florea, Dietrich Büsselberg (2011) Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects. 3(1), 1351-1371.

Abdulhakeem Al-Majed, Mohamed Sayed-Ahmed, Abdulaziz Al-Yahya, Abdulaziz Aleisa, Salim Al-Rejaie, Othman Al-Shabanah (2006) Propionyl-l-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model. 53(3), 278-286.

S Shanmugasundaram, R Bharathithasan, S Elangovan (2002) Detection of anthracycline induced cardiotoxicity by cardiac biomarkers. 72, S46.

M Yousef, A Saad, L El-Shennawy (2009) Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. 47, 1176-1183.

N Hopman, G Wipkink-Bakker, A Lentjes, E Berger, H Cleton, F Osanto, S (1998) Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. 9, 1331-1337.

Cecília Silva, Lusânia Greggi Antunes, Maria Bianchi (2001) Antioxidant action of bixin against cisplatin-induced chromosome aberrations and lipid peroxidation in rats. 43(6), 561-566.

D Lind, Maria Kontaridis, Paul Edwards, Michael Josephs, Lyle Moldawer, Edward Copeland (1997) Nitric Oxide Contributes to Adriamycin's Antitumor Effect. 69(2), 283-287.

H Ischiropoulos, L Zhu, J Beckman (1992) Peroxynitrite formation from macrophagederived nitric oxide. 298, 446-451.

R Radi, J Beckman, K Bush, B Freeman (1991) Peroxynitrite oxidation of sulfhydryls. The cytosolic potential of superoxide and nitric oxide. 266, 4244-4250.

M Hong, J Hong, S Stepkowski, B Kahan (2005) Correlation Between Cyclosporine-Induced Nephrotoxicity in Reduced Nephron Mass and Expression of Kidney Injury Molecule-1 and Aquaporin-2 Gene. 37(10), 4254-4258.

Grraphpad (1993) Unknown Title.

D Van-Hoff, R Schilsky, C Reichert (1979) Toxic effects of cis-dichlorodiammine platinum in man. 63, 1527-1531.

Jairam Sastry, Stewart Kellie (2005) SEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINE. 22(5), 441-445.

E Elawady, Y Moustafa, D Abo-Elmatty, M, Radwan (2011) Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies. 650, 335-341.

J Wang, D He, Q Zhang, Y Han, S Jin, F Qi (2009) Resveratrol Protects Against Cisplatin-Induced Cardiotoxicity by Alleviating Oxidative Damage: Cancer biotherapy and radio pharmaceuticals. 6, 675-681.

K Conklin, G Nicolson (2008) Molecular replacement in cancer therapy: reversing cancer metabolic and mitochondrial dysfunction, fatigue and the adverse effects of cancer therapy. 4, 66-76.

M Fariss, C Chan, M Patel, B Van Houten, S Orrenius (2005) Role of mitochondria in toxic oxidative stress. 5(2), 94-111.

N Santos, C Bezerra, N Martins, C Curti, M Bianchi, A Santos (2008) Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. 61(1), 145-155.

N Santos, C Catão, N Martins, C Curti, M Bianchi, A Santos (2007) Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. 81(7), 495-504.

Minoru Satoh, Naoki Kashihara, Sohachi Fujimoto, Hideyuki Horike, Takehiko Tokura, Tamehachi Namikoshi, Tamaki Sasaki, Hirofumi Makino (2003) A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo. 305(3), 1183-1190.

Jae-Sung Kim, Lihua He, John Lemasters (2003) Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. 304(3), 463-470.

G Kroemer, J Reed (2000) Mitochondrial control of cell death. 6, 513-519.

Istvan Arany, Robert Safirstein (2003) Cisplatin nephrotoxicity. 23(5), 460-464.

K Karthikeyan, B Bai, S Devaraj (1999) Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats. 115(3), 326-333.